Prevention of Third Stage Bleeding by Using Misoprostol

Postpartum haemorrhage accounts for nearly 28% of maternalmortality in developing countries. This prospective study ofthird stage bleeding prevention was conducted among the 96patients, who got admitted into the OBGY units of DhakaMedical College Hospital for normal vaginal delivery. 96patients were allocated to receive either 600 µg misoprostolorally (57 patients) or rectally (37 patients) 5 min after cordclamping and cutting. The primary objective was to find outwhether there was any dissimilarity present between these tworoutes of misoprostol in case of blood loss in third stage oflabor. A total of 59 patients received 600 mug of misoprostolorally, while 37 rectally. Both groups were comparable indemographic and parital data.